Approvals/TGA/Fluticasone+Salmeterol Cipla 250/25 fluticasone propionate/salmeterol (as xinafoate) 250/25 microgram inhalation pressurised aerosol can metered dose

Approved

STANDARD

Fluticasone+Salmeterol Cipla 250/25 fluticasone propionate/salmeterol (as xinafoate) 250/25 microgram inhalation pressurised aerosol can metered dose

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: b86043bca968d527
Company: Cipla Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: b86043bca968d527
Product Name: Fluticasone+Salmeterol Cipla 250/25 fluticasone propionate/salmeterol (as xinafoate) 250/25 microgram inhalation pressurised aerosol can metered dose
Artg Id: 267107
Artg Name: Fluticasone+Salmeterol Cipla 250/25 fluticasone propionate/salmeterol (as xinafoate) 250/25 microgram inhalation pressurised aerosol can metered dose
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2016-12-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/b7144b9dca91a171759b3a61513796ee.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/0ce5de6867718cf7dc5a124c0330f93c.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

b86043bca968d527

Type

Standard

Back to TGA Approvals